Correlation Between Seer and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Seer and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seer and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seer Inc and Aerovate Therapeutics, you can compare the effects of market volatilities on Seer and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seer with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seer and Aerovate Therapeutics.
Diversification Opportunities for Seer and Aerovate Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Seer and Aerovate is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Seer Inc and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Seer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seer Inc are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Seer i.e., Seer and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Seer and Aerovate Therapeutics
Given the investment horizon of 90 days Seer Inc is expected to generate 1.15 times more return on investment than Aerovate Therapeutics. However, Seer is 1.15 times more volatile than Aerovate Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 231.00 in Seer Inc on September 18, 2024 and sell it today you would earn a total of 3.00 from holding Seer Inc or generate 1.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Seer Inc vs. Aerovate Therapeutics
Performance |
Timeline |
Seer Inc |
Aerovate Therapeutics |
Seer and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Seer and Aerovate Therapeutics
The main advantage of trading using opposite Seer and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seer position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.Seer vs. Oric Pharmaceuticals | Seer vs. Anebulo Pharmaceuticals | Seer vs. Cullinan Oncology LLC | Seer vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Stocks Directory Find actively traded stocks across global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |